Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 Jul 22;8(7):e69269.
doi: 10.1371/journal.pone.0069269. Print 2013.

Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials

Affiliations
Meta-Analysis

Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials

Francesca Sperati et al. PLoS One. .

Abstract

In recent years, the scientific evidence linking vitamin D status or supplementation to breast cancer has grown notably. To investigate the role of vitamin D supplementation on breast cancer incidence, we conducted a systematic review and meta-analysis of randomized controlled trials comparing vitamin D with placebo or no treatment. We used OVID to search MEDLINE (R), EMBASE and CENTRAL until April 2012. We screened the reference lists of included studies and used the "Related Article" feature in PubMed to identify additional articles. No language restrictions were applied. Two reviewers independently extracted data on methodological quality, participants, intervention, comparison and outcomes. Risk Ratios and 95% Confident Intervals for breast cancer were pooled using a random-effects model. Heterogeneity was assessed using the I(2) test. In sensitivity analysis, we assessed the impact of vitamin D dosage and mode of administration on treatment effects. Only two randomized controlled trials fulfilled the pre-set inclusion criteria. The pooled analysis included 5372 postmenopausal women. Overall, Risk Ratios and 95% Confident Intervals were 1.11 and 0.74-1.68. We found no evidence of heterogeneity. Neither vitamin D dosage nor mode of administration significantly affected breast cancer risk. However, treatment efficacy was somewhat greater when vitamin D was administered at the highest dosage and in combination with calcium (Risk Ratio 0.58, 95% Confident Interval 0.23-1.47 and Risk Ratio 0.93, 95% Confident Interval 0.54-1.60, respectively). In conclusions, vitamin D use seems not to be associated with a reduced risk of breast cancer development in postmenopausal women. However, the available evidence is still limited and inadequate to draw firm conclusions. Study protocol code: FARM8L2B5L.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow diagram of the trial selection process.
Figure 2
Figure 2. Risk of bias summary.
Legend to Figure 2. Reviewers’ judgment on each “Risk of bias” item within each included study.
Figure 3
Figure 3. Forest plot of vitamin D supplementation and breast cancer incidence.
Legend to Figure 3. M–H, Mantel-Haenszel; 95% CI, 95% confidence interval; df, degrees of freedom.
Figure 4
Figure 4. Forest plot of vitamin D supplementation and breast cancer incidence.
Administration mode on treatment effects. Legend to Figure 4. M–H, Mantel-Haenszel; 95% CI, 95% confidence interval; df, degrees of freedom.

References

    1. Grant WB (2003) Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results. Cancer Res 164: 371–377. - PubMed
    1. Zittermann A, Schleithoff SS, Koerfer R (2005) Putting vitamin D and cardiovascular diseases into perspective. Br J Nutr 94(4): 483–492. - PubMed
    1. Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79: 362–71. - PubMed
    1. Giovannucci E (2005) The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 16: 83–95. - PubMed
    1. Garland CF, Grant W, Mohr SB, Gorham ED, Garland FC (2007) What is the dose-response relationship between vitamin D and cancer risk? Nutr Rev 65: S91–5. - PubMed

Publication types